Fatty Liver and Lipotropic Factors — MCQs

10 questions

A patient with high triglycerides (TG) esterified with long-chain fatty acids (LCFA) presents with fatigue, and a biopsy of the muscle shows fat vacuoles. What is the most likely diagnosis?

A patient with a history of alcohol dependence syndrome presents with sudden and unintentional weight loss. What is the most likely diagnosis?

A 50-year-old man with a history of alcohol abuse is found to have elevated liver enzymes, and a liver biopsy shows the microscopic features of steatosis. If the patient abstains from further drinking, this condition will most likely evolve into which of the following?

Which drug is associated with causing microvesicular fatty liver?

Patient with Type I diabetes mellitus, with complaints of polyuria. Which of the following will occur normally in his body?

Which of the following medications is primarily used to decrease serum triglycerides?

Which of the following is a lipotropic factor?

Which protein hormone is often referred to as the 'guardian angel against obesity' due to its role in regulating metabolism?

In a patient with lipoprotein lipase deficiency, which of the following is increased following a fatty meal?

Q10

Lipogenesis is stimulated by?

Fatty Liver and Lipotropic Factors Indian Medical PG Practice Questions and MCQs

Question 1: A patient with high triglycerides (TG) esterified with long-chain fatty acids (LCFA) presents with fatigue, and a biopsy of the muscle shows fat vacuoles. What is the most likely diagnosis?

A. Carnitine deficiency (Correct Answer)
B. Fatty acid synthase defect
C. Lipoprotein lipase (LPL) defect
D. LDL defect
E. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency

Explanation: ***Carnitine deficiency*** - **Carnitine** is essential for transporting **long-chain fatty acids (LCFAs)** into the mitochondria for beta-oxidation. - A deficiency leads to the accumulation of **LCFAs** as **triglycerides** in the cytoplasm, resulting in **fat vacuoles** in muscle and systemic fatigue due to impaired energy production. *Fatty acid synthase defect* - **Fatty acid synthase** is involved in the *de novo* synthesis of fatty acids, not their catabolism or transport. - A defect would impair fatty acid production, not lead to the accumulation of **triglycerides** from exogenous sources. *Lipoprotein lipase (LPL) defect* - **LPL** is crucial for cleaving **triglycerides** in circulating chylomicrons and VLDL, allowing fatty acids to be taken up by tissues. - A defect causes severe hypertriglyceridemia, but the primary issue in the muscle with fat vacuoles points towards a problem with intracellular fatty acid utilization rather than plasma triglyceride clearance. *LDL defect* - **LDL** is primarily responsible for transporting cholesterol to peripheral tissues. - Defects in **LDL** metabolism typically lead to hypercholesterolemia, not the accumulation of **triglycerides** or muscle fat vacuoles as described. *Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency* - **MCAD** deficiency is a fatty acid oxidation disorder affecting **medium-chain fatty acids** (C6-C12), not the **long-chain fatty acids** specifically mentioned in the stem. - It typically presents with hypoketotic hypoglycemia during fasting, often in infancy or childhood, rather than the characteristic muscle fat vacuole accumulation pattern seen with **carnitine deficiency**.

Question 2: A patient with a history of alcohol dependence syndrome presents with sudden and unintentional weight loss. What is the most likely diagnosis?

A. Hepatic adenoma
B. Cholangiocarcinoma
C. Hepatocellular carcinoma (Correct Answer)
D. Alcoholic hepatitis

Explanation: ***Hepatocellular carcinoma*** - The **alpha-fetoprotein (AFP)** level of **600 ng/mL** is significantly elevated, suggesting a diagnosis of hepatocellular carcinoma, especially in a patient with a history of **alcohol dependence syndrome** [1]. - The **AST/ALT ratio of 0.5** indicates significant liver damage, commonly seen in chronic liver disease leading to **hepatocellular cancer**. *Alcoholic hepatitis* - Typically presents with **elevated AST and ALT**, usually with a ratio >2:1, which is not the case here [2]. - May cause weight loss, as alcoholic patients often lose weight due to self-neglect and poor dietary intake, but the **elevated AFP** is not characteristic of merely alcoholic hepatitis [3]. *Cholangiocarcinoma* - This type of cancer primarily presents with **biliary obstruction** symptoms, such as jaundice, which is not indicated here given **normal bilirubin levels**. - Does not typically lead to such high levels of **AFP**, making it less likely with the provided lab results. *Hepatic adenoma* - More commonly associated with **oral contraceptive use** or anabolic steroid use, not primarily alcohol dependence. - AFP levels are usually normal or only mildly elevated in hepatic adenoma, making this option less viable with an **AFP level of 600 ng/mL**.

Question 3: A 50-year-old man with a history of alcohol abuse is found to have elevated liver enzymes, and a liver biopsy shows the microscopic features of steatosis. If the patient abstains from further drinking, this condition will most likely evolve into which of the following?

A. Acute liver injury
B. Chronic liver disease
C. Cirrhosis
D. Complete resolution (Correct Answer)

Explanation: ***Complete regression*** - Abstaining from alcohol can lead to **complete regression** of steatosis as the liver has a remarkable ability to heal and regenerate when inflammation is not present [1]. - With sustained abstinence, the liver enzymes can return to normal and the steatosis may resolve fully within months [1]. *Chronic hepatitis* - Chronic hepatitis is characterized by ongoing **inflammation** and potential liver damage, which is not typically seen when a patient successfully abstains from alcohol. - This condition usually occurs after prolonged liver injury, rather than as a direct evolution from steatosis with abstinence. *Acute hepatitis* - Acute hepatitis usually presents with **sudden onset of liver inflammation** often caused by viral infections or toxins, rather than alcoholic liver steatosis. - In the context of alcohol, acute hepatitis would indicate recent and severe liver damage, which differs when the patient avoids further alcohol. *Hyperplastic nodules* - Hyperplastic nodules are associated with advanced liver disease, often seen in conditions like **cirrhosis**, rather than directly evolving from steatosis after alcohol cessation. - These nodules develop as a compensatory response in chronic liver disease, which is not expected if the steatosis resolves.

Question 4: Which drug is associated with causing microvesicular fatty liver?

A. Valproate (Correct Answer)
B. Reye's Syndrome
C. Non-alcoholic fatty liver disease (NAFLD)
D. Acute Fatty Liver of Pregnancy (AFLP)

Explanation: ***Valproate*** - Valproate is a well-documented cause of **drug-induced microvesicular steatosis**, particularly in children - It interferes with **mitochondrial beta-oxidation** of fatty acids, leading to accumulation of small lipid droplets within hepatocytes - The microvesicular pattern is characterized by small fat droplets that do not displace the nucleus - Risk is higher in children under 2 years, those on polytherapy, and patients with metabolic disorders *Reye's Syndrome* - While Reye's Syndrome does cause microvesicular steatosis, it is a **syndrome** (not a drug), typically associated with viral illness and aspirin use in children - It presents with acute encephalopathy and liver dysfunction - Not a pharmacological agent itself *Non-alcoholic fatty liver disease (NAFLD)* - NAFLD causes **macrovesicular steatosis**, not microvesicular - Large lipid droplets displace the hepatocyte nucleus to the periphery - Associated with metabolic syndrome, obesity, and insulin resistance *Acute Fatty Liver of Pregnancy (AFLP)* - AFLP does cause microvesicular steatosis but is a **pregnancy-related condition**, not a drug - Occurs in the third trimester and is a medical emergency - Related to defects in mitochondrial fatty acid oxidation

Question 5: Patient with Type I diabetes mellitus, with complaints of polyuria. Which of the following will occur normally in his body?

A. Increased protein synthesis
B. Glycogenesis in muscle
C. Decreased cholesterol synthesis
D. Increased conversion of fatty acid to acetyl CoA (Correct Answer)

Explanation: ***Increased conversion of fatty acid to acetyl CoA*** - In response to **insulin deficiency** and **hyperglycemia** in Type 1 diabetes, the body shifts from carbohydrate to fat metabolism. - This leads to increased **lipolysis**, releasing fatty acids that are then converted to **acetyl CoA** in the liver for energy or ketone body production. *Incorrect: Increased protein synthesis* - **Insulin** is an **anabolic hormone** that promotes protein synthesis; its deficiency in Type 1 diabetes leads to decreased, not increased, protein synthesis. - Instead, there's often increased **protein catabolism** to provide substrates for gluconeogenesis. *Incorrect: Glycogenesis in muscle* - **Insulin** is required for the uptake of glucose into muscle cells and its subsequent conversion to **glycogen (glycogenesis)**. - In Type 1 diabetes, the lack of insulin significantly impairs muscle glucose uptake and glycogenesis. *Incorrect: Decreased cholesterol synthesis* - In uncontrolled Type 1 diabetes, there is actually **increased cholesterol synthesis**, not decreased. - The increased availability of **acetyl CoA** (from enhanced fatty acid oxidation) provides substrate for cholesterol synthesis via the **HMG-CoA reductase pathway**. - This contributes to the **dyslipidemia** commonly seen in poorly controlled diabetes, including elevated LDL cholesterol and total cholesterol levels.

Question 6: Which of the following medications is primarily used to decrease serum triglycerides?

A. Fibrates (Correct Answer)
B. Ezetimibe
C. Niacin
D. Statin

Explanation: ***Fibrates*** - Fibrates, such as **gemfibrozil** and **fenofibrate**, are primarily used to activate **PPAR-alpha**, leading to increased lipoprotein lipase activity and reduced hepatic triglyceride synthesis. - This effectively lowers **serum triglyceride levels** by 20-50% and can also increase HDL cholesterol. *Statin* - Statins primarily inhibit **HMG-CoA reductase**, the rate-limiting enzyme in cholesterol synthesis, which makes them highly effective at lowering **LDL cholesterol**. - While they can cause a modest reduction in triglycerides (10-30%), this is not their primary mechanism or indication. *Ezetimibe* - Ezetimibe works by inhibiting the absorption of **cholesterol** at the brush border of the small intestine, thereby lowering **LDL cholesterol**. - It has minimal effect on **triglyceride levels** and is not indicated for primary triglyceride reduction. *Niacin* - Niacin, or **nicotinic acid**, reduces the liver's production of VLDL (which contains triglycerides) and LDL, and also increases HDL cholesterol. - While it can significantly lower triglycerides, its use is often limited by bothersome side effects such as **flushing** and itchiness, making fibrates generally preferred for primary triglyceride lowering due to better tolerability.

Question 7: Which of the following is a lipotropic factor?

A. Sphingomyelin
B. Histidine
C. Bilirubin
D. Methionine (Correct Answer)

Explanation: ***Methionine*** - **Methionine** is an essential amino acid that serves as a precursor for **choline** and **creatine**, both of which play crucial roles in lipid metabolism and transport. - Lipotropic factors prevent or reverse the accumulation of **fat in the liver** by promoting the synthesis of **lipoproteins**, which package and transport fats from the liver to other tissues. *Sphingomyelin* - **Sphingomyelin** is a type of **sphingolipid**, a component of cell membranes and myelin sheaths, but it does not directly act as a lipotropic factor to prevent fatty liver. - While it's involved in cellular signaling and membrane structure, it does not directly facilitate the metabolism or transport of **hepatic triglycerides** in the same way as lipotropic agents. *Histidine* - **Histidine** is an essential amino acid involved in protein synthesis and the production of **histamine**, but it is not considered a primary lipotropic factor. - Its main roles are in **immune response** and **neurotransmission**, not in preventing fat accumulation in the liver. *Bilirubin* - **Bilirubin** is a waste product from the breakdown of **heme**, primarily from red blood cells. It is excreted by the liver. - It is known for its **antioxidant properties** but does not play a direct role as a lipotropic factor in lipid metabolism or in preventing **fatty liver**.

Question 8: Which protein hormone is often referred to as the 'guardian angel against obesity' due to its role in regulating metabolism?

A. Adiponectin (Correct Answer)
B. Fibronectin
C. High-Density Lipoprotein (HDL)
D. Insulin

Explanation: ***Adiponectin*** - **Adiponectin** is a hormone secreted by **adipose tissue** that plays a crucial role in regulating glucose and fatty acid metabolism, increasing **insulin sensitivity**, and decreasing inflammation. - Its levels are inversely correlated with body fat percentage; individuals with obesity tend to have lower adiponectin levels, leading to its nickname as the 'guardian angel against obesity'. *Fibronectin* - **Fibronectin** is a glycoprotein involved in cell adhesion, growth, migration, and differentiation, and is a key component of the **extracellular matrix**. - It does not primarily function in metabolic regulation or body weight control, unlike adiponectin. *High-Density Lipoprotein (HDL)* - **HDL** is a type of lipoprotein that transports cholesterol from peripheral tissues back to the liver, a process known as **reverse cholesterol transport**. - While beneficial for cardiovascular health, HDL is a lipid-carrying particle, not a protein hormone, and its primary role is not in metabolic regulation or direct obesity prevention. *Insulin* - **Insulin** is a peptide hormone produced by the pancreas that regulates carbohydrate and fat metabolism, primarily by facilitating glucose uptake from the blood into cells. - While essential for metabolism, high levels of insulin in the context of insulin resistance can contribute to obesity, rather than act against it.

Question 9: In a patient with lipoprotein lipase deficiency, which of the following is increased following a fatty meal?

A. Chylomicron (Correct Answer)
B. LDL
C. HDL
D. Apo-A

Explanation: ***Chylomicron*** - Lipoprotein lipase (LPL) is essential for the breakdown of **chylomicrons** in the bloodstream. A deficiency in LPL means chylomicrons cannot be cleared effectively. - After a **fatty meal**, the body absorbs dietary fats as chylomicrons. Without functional LPL, these chylomicrons accumulate in the plasma, leading to **marked elevation** of chylomicron levels. - This results in **lipemic (milky) serum**, a characteristic finding in Type I hyperlipoproteinemia. *LDL* - **LDL (Low-Density Lipoprotein)** levels are primarily affected by the metabolism of VLDL (Very Low-Density Lipoprotein), which is a separate pathway from chylomicron metabolism. - LPL deficiency specifically impacts chylomicron clearance, not directly causing an increase in LDL. In fact, LDL may be normal or even low in severe hypertriglyceridemia. *HDL* - **HDL (High-Density Lipoprotein)** is involved in reverse cholesterol transport and is typically **decreased** (not increased) in LPL deficiency. - During normal lipolysis by LPL, surface components from chylomicrons are transferred to HDL. In LPL deficiency, this process is impaired, leading to **reduced HDL levels**. *Apo-A* - **Apolipoprotein A-I (Apo-AI)** is the primary apolipoprotein found on HDL particles and is crucial for HDL formation and function. - Since HDL levels are decreased in LPL deficiency, Apo-AI levels would also be decreased (not increased) following a fatty meal.

Question 10: Lipogenesis is stimulated by?

A. Insulin (Correct Answer)
B. Glucagon
C. Epinephrine
D. Corticosteroids

Explanation: ***Insulin*** - **Insulin** is a key anabolic hormone that promotes the synthesis and storage of fat (lipogenesis) by increasing the uptake of glucose into adipose tissue and stimulating enzymes involved in fatty acid synthesis. - It enhances the conversion of excess carbohydrates into **triglycerides** for storage. *Glucagon* - **Glucagon** is a catabolic hormone that primarily promotes the breakdown of glycogen (glycogenolysis) and fat (lipolysis) to release glucose and fatty acids into the bloodstream, especially during fasting. - It generally **inhibits** lipogenesis and stimulates **gluconeogenesis**. *Epinephrine* - **Epinephrine** (adrenaline) is a stress hormone that promotes the breakdown of fat (lipolysis) to provide energy during acute stress or exercise. - It would **inhibit** lipogenesis, as its primary role is to mobilize energy stores. *Corticosteroids* - While **corticosteroids** can influence fat metabolism, their effect on lipogenesis is complex and often indirect. High levels can lead to fat redistribution (e.g., central obesity) rather than direct stimulation of overall lipogenesis. - Corticosteroids generally promote **lipolysis** in the extremities and can contribute to insulin resistance, which would hinder lipogenesis in some tissues.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free